Treatable causes of diarrhoea in patients on tyrosine kinase inhibitors for metastatic renal cell carcinoma.

Lightowlers, S V; Greef, B; Eisen, T; Matakidou, A; Fife, K; Cameron, E A

Lightowlers, S V; Greef, B; Eisen, T; Matakidou, A; Fife, K; Cameron, E A.

Afiliación

Lightowlers SV; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge.
Greef B; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge.
Eisen T; Department of Oncology, University of Cambridge, Cambridge; AstraZeneca, Cambridge.
Matakidou A; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge; AstraZeneca, Cambridge.
Fife K; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge. Electronic address: kate.fife@addenbrookes.nhs.uk.
Cameron EA; Department of Gastroenterology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Ann Oncol ; 30(1): 150-151, 2019 01 01.

Article en En | MEDLINE | ID: mdl-30358823

Asunto(s)

Antibacterianos/uso terapéutico; Carcinoma de Células Renales/tratamiento farmacológico; Diarrea/tratamiento farmacológico; Neoplasias Renales/tratamiento farmacológico; Inhibidores de Proteínas Quinasas/efectos adversos; Carcinoma de Células Renales/secundario; Diarrea/inducido químicamente; Humanos; Neoplasias Renales/patología; Pronóstico

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Inhibidores de Proteínas Quinasas / Diarrea / Neoplasias Renales / Antibacterianos Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google